Evaluating Cardiac Function in Patients with Liver Cirrhosis

Abstract

Background and Aim: Cirrhotic cardiomyopathy affects heart health, while cardiac cirrhosis affects liver function. Both circumstances can occur simultaneously. Aim of the study was to evaluate cardiac function in patient of liver cirrhosis. Material and Methods: This study was carried out in the department of medicine, SMIMER hospital, Surat, Gujarat from June 2012 to august 2013. 50 patients, fulfilling the inclusion criteria. A thorough clinical history and examination were conducted for every patient presenting with liver cirrhosis. Fifty cirrhotic patients and were hospitalized and their pulse, blood pressure, ECG were obtained; blood was taken for liver function test, renal function test, Prothrombin time and complete blood count. Simultaneously 2D-echocardiography was performed in all 50 patients and various cardiac parameters were measured. Results: There Was a rise in both the LVPW and IVS components. The patients we had exhibited a higher PAP. Among fifty patients, thirty-three were identified as having ME/MA. Consequently, around 66% of patients, which equates to 33 out of 50, were identified as having diastolic dysfunction. Our findings indicate that there is no significant difference between our study and the previous one regarding LVDD, RVDD, EF%, ME, MA, ME/MA, and DT (mitral). There is significantly higher QTc interval in cirrhotic patients. significant diastolic dysfunction was noted in cirrhotic patients (66% of total patients). Conclusion: In individuals with cirrhosis, the QTc interval is significantly prolonged compared to those who are healthy. Individuals with cirrhosis experienced a significant enlargement of both their right and left atriums. Research indicated that individuals with cirrhosis did not demonstrate any notable alterations in the size of their left and right ventricles.